MyFinsight
Home
Blog
About
Proceeds from maturities
and sales of...
$17,110K
(-47.49%↓ Y/Y)
Proceeds from employee
stock purchase plan
$99K
(32.00%↑ Y/Y)
Proceeds from exercise of
stock options
$41K
(-14.58%↓ Y/Y)
Net cash provided by
(used in) investing...
$6,394K
(116.16%↑ Y/Y)
Net cash provided by
financing activities
$140K
(-99.74%↓ Y/Y)
Canceled cashflow
$10,716K
Net increase in cash
and cash...
$223K
(-77.08%↓ Y/Y)
Canceled cashflow
$6,311K
Purchases of marketable
securities
$10,664K
(-85.16%↓ Y/Y)
Purchase of intangible
assets
$36K
Purchases of property and
equipment
$16K
(-94.37%↓ Y/Y)
Stock-based compensation
$823K
(-70.99%↓ Y/Y)
Accounts payable
$811K
(183.87%↑ Y/Y)
Prepaid expenses and
other assets
-$449K
(25.54%↑ Y/Y)
Accrued and other
current liabilities
$287K
(429.89%↑ Y/Y)
Non-cash investment
income, net
-$224K
(-474.36%↓ Y/Y)
Depreciation and
amortization
$191K
(-57.84%↓ Y/Y)
Non-cash lease expense
$58K
(-80.73%↓ Y/Y)
Accounts receivable
-$1K
(94.12%↑ Y/Y)
Net cash used in
operating activities
-$6,311K
(51.55%↑ Y/Y)
Canceled cashflow
$2,844K
Other income, net
$867K
(-63.00%↓ Y/Y)
Net loss
-$9,139K
(43.70%↑ Y/Y)
Canceled cashflow
$867K
Deferred revenue
-$14K
(-366.67%↓ Y/Y)
Other
$2K
(-60.00%↓ Y/Y)
Revenue
$30K
(-45.45%↓ Y/Y)
Loss from operations
-$10,004K
(46.13%↑ Y/Y)
Canceled cashflow
$30K
Interest expense
$2K
(-66.67%↓ Y/Y)
Payroll related
expenses
$5,487K
(-30.47%↓ Y/Y)
Consulting and
professional fees
$1,641K
(-57.65%↓ Y/Y)
Other segment items
$1,363K
(-32.69%↓ Y/Y)
Stock-based compensation
expense
$823K
(-70.99%↓ Y/Y)
Equipment, lab supplies,
and facility...
$354K
(-55.92%↓ Y/Y)
Depreciation and
amortization
$162K
(-58.99%↓ Y/Y)
Clinical studies and
outside processing
$154K
(-78.52%↓ Y/Y)
Cost of revenue
$50K
(-38.27%↓ Y/Y)
Back
Back
Cash Flow
SERA PROGNOSTICS, INC. (SERA)
SERA PROGNOSTICS, INC. (SERA)
source: myfinsight.com